scholarly journals Reproductive Health and Medication Concerns for Patients With Inflammatory Bowel Disease: Thematic and Quantitative Analysis Using Social Listening

2018 ◽  
Vol 20 (6) ◽  
pp. e206 ◽  
Author(s):  
Michelle Sophie Keller ◽  
Sasan Mosadeghi ◽  
Erica R Cohen ◽  
James Kwan ◽  
Brennan Mason Ross Spiegel
2010 ◽  
Vol 138 (5) ◽  
pp. S-522
Author(s):  
Nadan Rustemovic ◽  
Silvija Cukovic-Cavka ◽  
Marko Brinar ◽  
Davor Radic ◽  
Milorad Opacic ◽  
...  

2018 ◽  
Vol 48 (11-12) ◽  
pp. 1202-1212 ◽  
Author(s):  
Satvinder Purewal ◽  
Sarah Chapman ◽  
Wladyslawa Czuber-Dochan ◽  
Christian Selinger ◽  
Helen Steed ◽  
...  

2018 ◽  
Author(s):  
Michelle Sophie Keller ◽  
Sasan Mosadeghi ◽  
Erica R Cohen ◽  
James Kwan ◽  
Brennan Mason Ross Spiegel

BACKGROUND Inflammatory bowel disease (IBD) affects many individuals of reproductive age. Most IBD medications are safe to use during pregnancy and breastfeeding; however, observational studies find that women with IBD have higher rates of voluntary childlessness due to fears about medication use during pregnancy. Understanding why and how individuals with IBD make decisions about medication adherence during important reproductive periods can help clinicians address patient fears about medication use. OBJECTIVE The objective of this study was to gain a more thorough understanding of how individuals taking IBD medications during key reproductive periods make decisions about their medication use. METHODS We collected posts from 3000 social media sites posted over a 3-year period and analyzed the posts using qualitative descriptive content analysis. The first level of analysis, open coding, identified individual concepts present in the social media posts. We subsequently created a codebook from significant or frequently occurring codes in the data. After creating the codebook, we reviewed the data and coded using our focused codes. We organized the focused codes into larger thematic categories. RESULTS We identified 7 main themes in 1818 social media posts. Individuals used social media to (1) seek advice about medication use related to reproductive health (13.92%, 252/1818); (2) express beliefs about the safety of IBD therapies (7.43%, 135/1818); (3) discuss personal experiences with medication use (16.72%, 304/1818); (4) articulate fears and anxieties about the safety of IBD therapies (11.55%, 210/1818); (5) discuss physician-patient relationships (3.14%, 57/1818); (6) address concerns around conception, infertility, and IBD medications (17.38%, 316/1818); and (7) talk about IBD symptoms during and after pregnancy and breastfeeding periods (11.33%, 206/1818). CONCLUSIONS Beliefs around medication safety play an important role in whether individuals with IBD decide to take medications during pregnancy and breastfeeding. Having a better understanding about why patients stop or refuse to take certain medications during key reproductive periods may allow clinicians to address specific beliefs and attitudes during office visits.


2019 ◽  
Vol 13 (6) ◽  
pp. 815-815
Author(s):  
Pierre Ellul ◽  
Stefania Chetcuti Zammit ◽  
Konstantinos H Katsanos ◽  
Monica Cesarini ◽  
Mariangela Allocca ◽  
...  

2020 ◽  
Vol 19 (1) ◽  
pp. 48-56
Author(s):  
Sara M. B. Cunha ◽  
Maria C. F. Carneiro ◽  
Cátia D. Rodrigues ◽  
Cátia L. S. N. S. Rasteiro ◽  
Teresa P. Teles

Introduction: Inflammatory bowel disease is a chronicidiopathic condition involving the gastrointestinal tract.The disease prevalence is increasing worldwide, affectingwomen in childbearing age. Objective: Clinical and practicalreview of the women´s sexual and reproductive health ininflammatory bowel disease with focus in gynaecologicaland obstetrical management. Materials and Methods: In thisarticle we review sexual and reproductive health issues inwomen with inflammatory bowel disease in all life stagesand the main particularities of the approach of inflammatorybowel disease in pregnancy and breastfeeding. Results andConclusion: Fertility in women without disease activity isnot decreased comparing to general population, but despiteresearch is inconsistent there are reports of increased risk ofsmall for gestational age, preterm delivery, low Apgar score,congenital anomalies, intrauterine death, miscarriage, venousthromboembolism and preeclampsia. To improve obstetricoutcomes, a period of 3 to 6 months of disease remission isrecommended before conception. Medication adjustmentmay be necessary, and supplementation should be adapted. Amultidisciplinary approach and a comprehensive knowledgeof the disease through all women life stages allows a betterhealth care.Keywords: Inflammatory bowel disease, Sexual health,Reproduction, Pregnancy, Breastfeeding.


Author(s):  
Alessandro Armuzzi ◽  
Aurora Bortoli ◽  
Fabiana Castiglione ◽  
Antonella Contaldo ◽  
Marco Daperno ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document